88 related articles for article (PubMed ID: 10918286)
1. Flow cytometric assessment of allopurinol susceptibility in Leishmania infantum promastigote.
Kamau SW; Hurtado M; Müller-Doblies UU; Grimm F; Nunez R
Cytometry; 2000 Aug; 40(4):353-60. PubMed ID: 10918286
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric assessment of drug susceptibility in Leishmania infantum promastigotes.
Nuñez R; Kamau S; Grimm F
Curr Protoc Cytom; 2001 May; Chapter 11():Unit 11.14. PubMed ID: 18770688
[TBL] [Abstract][Full Text] [Related]
3. Leishmania infantum promastigotes: flow cytometry as a possible tool for assessing the effects of drugs on cellular functions.
Azas N; Di Giorgio C; Delmas F; Gasquet M; Timon-David P
Exp Parasitol; 1997 Sep; 87(1):1-7. PubMed ID: 9287952
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantum promastigotes.
Kamau SW; Nunez R; Grimm F
BMC Pharmacol; 2001; 1():1. PubMed ID: 11299045
[TBL] [Abstract][Full Text] [Related]
5. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
[TBL] [Abstract][Full Text] [Related]
6. Activity of (-)alpha-bisabolol against Leishmania infantum promastigotes.
Morales-Yuste M; Morillas-Márquez F; Martín-Sánchez J; Valero-López A; Navarro-Moll MC
Phytomedicine; 2010 Mar; 17(3-4):279-81. PubMed ID: 19577452
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of polyamine derivative compounds against Leishmania infantum promastigotes and axenic amastigotes.
Tavares J; Ouaissi A; Lin PK; Tomás A; Cordeiro-da-Silva A
Int J Parasitol; 2005 May; 35(6):637-46. PubMed ID: 15862577
[TBL] [Abstract][Full Text] [Related]
8. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
10. Assessment of amphotericin B susceptibility in Leishmania infantum promastigotes by flow cytometric membrane potential assay.
Azas N; Di Giorgio C; Delmas F; Gasquet M; Timon-David P
Cytometry; 1997 Jun; 28(2):165-9. PubMed ID: 9181307
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
[TBL] [Abstract][Full Text] [Related]
12. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
13. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs.
Daneshvar H; Molaei MM; Afshar RM; Kamiabi H; Burchmore R; Hagan P; Phillips RS
Vet Immunol Immunopathol; 2009 May; 129(1-2):28-35. PubMed ID: 19147233
[TBL] [Abstract][Full Text] [Related]
15. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the anti-Leishmania effect induced by cisplatin, an anticancer drug.
Tavares J; Ouaissi M; Ouaissi A; Cordeiro-da-Silva A
Acta Trop; 2007 Aug; 103(2):133-41. PubMed ID: 17658446
[TBL] [Abstract][Full Text] [Related]
17. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum.
Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P
Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213
[TBL] [Abstract][Full Text] [Related]
19. Changes in the proteome and infectivity of Leishmania infantum induced by in vitro exposure to a nitric oxide donor.
Dea-Ayuela MA; Ordoñez-Gutierrez L; Bolás-Fernández F
Int J Med Microbiol; 2009 Mar; 299(3):221-32. PubMed ID: 18774335
[TBL] [Abstract][Full Text] [Related]
20. No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes.
Azas N; Di Giorgio C; Delmas F; Gasquet M; Timon-David P
Parasite; 2001 Dec; 8(4):335-41. PubMed ID: 11802270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
